Ameriprise Financial Inc Selecta Biosciences Inc Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.67 - $1.35 $35,806 - $72,148	-53,443 Reduced 13.2%	351,483 $242,000
Q3 2023 Nov 14, 2023	SELL	$1.02 - $1.23 $3,674 - $4,430	-3,602 Reduced 0.88%	404,926 $429,000
Q2 2023 Aug 14, 2023	BUY	$1.04 - $1.4 $20,494 - $27,588	19,706 Added 5.07%	408,528 $457,000
Q1 2023 May 15, 2023	BUY	$1.15 - $1.89 $126,697 - $208,225	110,172 Added 39.54%	388,822 $540,000
Q4 2022 Feb 14, 2023	SELL	$0.96 - $1.6 $5,236 - $8,728	-5,455 Reduced 1.92%	278,650 $314,000
Q3 2022 Nov 14, 2022	SELL	$1.33 - $2.6 $11,555 - $22,588	-8,688 Reduced 2.97%	284,105 $466,000
Q2 2022 Aug 15, 2022	SELL	$0.67 - $1.4 $81,169 - $169,607	-121,148 Reduced 29.27%	292,793 $383,000
Q1 2022 May 16, 2022	BUY	$1.23 - $3.31 $151,318 - $407,206	123,023 Added 42.29%	413,941 $509,000
Q4 2021 Feb 14, 2022	BUY	$2.89 - $4.43 $840,753 - $1.29 Million	290,918 New	290,918 $949,000
Q3 2021 Nov 15, 2021	SELL	$3.36 - $4.62 $138,280 - $190,136	-41,155 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.82 - $5.01 $127,833 - $227,108	-45,331 Reduced 52.41%	41,155 $172,000
Q1 2021 May 17, 2021	SELL	$2.92 - $5.07 $12,526 - $21,750	-4,290 Reduced 4.73%	86,486 $391,000
Q4 2020 Feb 12, 2021	BUY	$1.64 - $3.42 $76,712 - $159,973	46,776 Added 106.31%	90,776 $275,000
Q3 2020 Nov 16, 2020	SELL	$2.18 - $2.84 $8,720 - $11,360	-4,000 Reduced 8.33%	44,000 $109,000
Q2 2020 Aug 14, 2020	BUY	$1.83 - $4.06 $87,840 - $194,879	48,000 New	48,000 $136,000
Q4 2018 Feb 14, 2019	SELL	$2.66 - $15.93 $359,233 - $2.15 Million	-135,050 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.07 - $16.0 $623,560 - $826,592	51,662 Added 61.95%	135,050 $2.1 Million
Q2 2018 Aug 14, 2018	BUY	$9.36 - $13.25 $780,511 - $1.1 Million	83,388 New	83,388 $1.11 Million

Others Institutions Holding SELB

# of Institutions

Shares Held

4.67M

Call Options Held

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account